Pharmacokinetics and pharmacodynamics of subcutaneously administered PYY3-36 and its analogues in vivo.

Cegla, Jaimini; Cuenco, Joyceline; Minnion, James; Ghourab, Samar; Hostomska, Klara; Tan, Tricia; Bloom, Stephen

Cegla, Jaimini; Cuenco, Joyceline; Minnion, James; Ghourab, Samar; Hostomska, Klara; Tan, Tricia; Bloom, Stephen.

Afiliación

Cegla J; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK. Electronic address: j.cegla@imperial.ac.uk.
Cuenco J; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Minnion J; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Ghourab S; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Hostomska K; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Tan T; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.
Bloom S; Division of Diabetes, Endocrinology & Metabolism, Imperial College London, London, UK.

Lancet ; 385 Suppl 1: S28, 2015 Feb 26.

Article en En | MEDLINE | ID: mdl-26312850

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Lancet Año: 2015 Tipo del documento: Article